PF-08065010
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-08065010, covering 2026-03-19 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults [Phase 1]